Evigrade

Calcium carbonate

AEMPS

Mineral supplements. Calcium

ATC code: A12AA04

Brand names: Tums, Caltrate, Os-Cal, Rolaids

Updated · Methodology

Indications

A

Mild hypocalcemia

First line

In mild asymptomatic hypocalcemia (total calcium 2.0–2.2 mmol/L), oral calcium at 1000–1500 mg elemental calcium daily plus vitamin D usually normalizes the level. Calcium is rechecked at 1–2 weeks. If hypocalcemia persists, magnesium, PTH, vitamin D and eGFR are evaluated.

ICD-10: E83.5 · ICD-11: 5C64.5

B

Antacid therapy for mild dyspepsia

Second line

For occasional heartburn and acid regurgitation, calcium carbonate as an antacid rapidly neutralizes acid and relieves symptoms. The effect is short-lived (30–60 minutes). Symptoms more than twice a week require workup (GERD, H. pylori, functional dyspepsia) and consideration of a PPI. Antacid use beyond 2 weeks without effect is reassessed.

ICD-10: K30 · ICD-11: DD90.3

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

F

Calcium monotherapy for osteoporosis

Not recommended

Calcium supplementation alone, without vitamin D and disease-modifying therapy, does not reduce fracture risk in most patients with confirmed osteoporosis. International guidelines treat calcium only as a background component combined with vitamin D and mandatory disease-modifying therapy (bisphosphonates, denosumab, romosozumab). «Calcium for bones» without full assessment and disease-modifying therapy is marketing positioning.

ICD-10: M81.9 · ICD-11: FB83.1

F

Primary CVD prevention with calcium supplements

Not recommended

Calcium supplementation for primary cardiovascular prevention is not indicated. The 2018 concluded that in asymptomatic postmenopausal women, additional calcium and vitamin D supplementation provides no advantage over a balanced diet for fracture and CVD prevention. The 2010–2013 meta-analyses (Bolland et al.) suggested a possible increase in MI risk with isolated calcium, although subsequent larger analyses have not confirmed the effect.

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

A source of elemental calcium, providing 40% by mass. In the stomach it dissociates into calcium and bicarbonate ions. Calcium is absorbed in the small intestine by active vitamin D-dependent transport and passive diffusion. Bicarbonate neutralizes hydrochloric acid – hence the antacid effect. Bioavailability depends on gastric acidity: hypoacidity or PPI therapy reduces absorption, in which case organic calcium salts (citrate) are preferred.

Safety

Contraindications

  • Hypercalcemia of any cause
  • Hypercalciuria with stone disease risk
  • Active urolithiasis
  • Severe renal impairment (eGFR < 30 mL/min/1.73 m²)
  • Sarcoidosis and other granulomatous diseases with hypercalcemia
  • Hypersensitivity to drug components

Serious adverse effects

  • Hypercalcemia with depressed consciousness, nausea and nephrocalcinosis
  • Milk-alkali syndrome at high doses combined with dairy intake
  • Acute kidney injury
  • Soft tissue calcification on prolonged hypercalcemia

Common adverse effects

  • Constipation
  • Flatulence, belching
  • Nausea

Uncommon adverse effects

  • Hypercalciuria at doses above 1500 mg elemental calcium daily
  • Acid rebound when used as antacid

Pregnancy: can you take Calcium carbonate?

AEMPS summary of product characteristics (section 4.6): calcium carbonate can be used during pregnancy. Daily calcium intake should not exceed 2,500 mg, because persistent hypercalcaemia has been linked to adverse effects on fetal development.

Breastfeeding: can you take Calcium carbonate?

Calcium is an essential component of a lactating mother's diet. Calcium supplementation at physiological doses is safe and compatible with breastfeeding.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Timing and administration

Taken with or right after meals for optimal absorption – gastric acidity increases bioavailability. Daily dose is split into 2–3 doses (maximum 500 mg elemental calcium is absorbed per dose; the rest is not used). Co-administration with milk drinks is not required and does not improve bioavailability.

Monitoring

With long-term use (over 6 months), monitor serum calcium, phosphorus, creatinine and 24-hour urinary calcium every 6 months. With hypercalciuria (over 7.5 mmol/day), the dose is reduced or the drug withdrawn.

Special situations

Maintain at least 2 hours between calcium carbonate and levothyroxine, fluoroquinolones, tetracyclines and bisphosphonates – calcium carbonate reduces their absorption. On PPIs or H2 blockers, calcium carbonate bioavailability is reduced – patients on long-term acid suppression should use calcium citrate or other organic salts. In oxalate stone disease, the dose is individualized and kept within the physiological range.

Common myths

Myth: «more calcium means stronger bones». Fact: beyond 1500 mg daily, additional calcium offers no extra benefit and increases hypercalciuria and stone disease risk.

Myth: «every woman over 40 needs calcium for osteoporosis prevention». Fact: the 2018 found no benefit of prophylactic supplementation in asymptomatic women. Adequate dietary intake is usually enough; supplements are indication-based after risk assessment.


Myth: «calcium and vitamin D alone treat osteoporosis». Fact: confirmed osteoporosis requires disease-modifying therapy (bisphosphonates, denosumab, romosozumab). Calcium and vitamin D are background components.

Drug–nutrient interactions

Levothyroxine

Calcium carbonate forms insoluble complexes with levothyroxine in the gut lumen and reduces its absorption. With concurrent dosing, the levothyroxine dose becomes insufficient, leading to hypothyroidism. A separation of at least 4 hours is maintained between fasting morning levothyroxine and calcium carbonate.

Fluoroquinolones

Calcium chelates with fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) and reduces their absorption by 30–50%. A separation of at least 2 hours before and 6 hours after a fluoroquinolone dose is maintained before calcium carbonate.

Bisphosphonates

Calcium chelates oral bisphosphonates (alendronate, risedronate, ibandronate) and blocks their absorption completely. Bisphosphonates are taken strictly fasting 30–60 minutes before breakfast, no later than the first meal and no earlier than 30 minutes before calcium. Failure to observe the interval nullifies antiresorptive therapy.

Iron

Calcium competes with iron for absorption in the duodenum. In patients with iron-deficiency anemia, a 2-hour interval between calcium and iron supplements is maintained.

Drug–drug interactions

12 pairs found. Sorted from critical to minor.

ModerateBisoprololSelective beta-adrenergic blockers

Mechanism

Calcium carbonate may reduce bisoprolol GI absorption when taken simultaneously. The effect is weak and clinically minor.

Symptoms

Minimal changes. In some patients, mild return of hypertension or angina symptoms with prolonged concurrent use.

Management

Separate bisoprolol and calcium carbonate by 2 hours. Most patients require no special adjustment.

Pair details →Bisoprolol →

ModerateCiprofloxacinFluoroquinolone antibacterials

Mechanism

Calcium forms insoluble chelates with ciprofloxacin in the gut. Antibiotic bioavailability falls by 40–50%, raising the risk of clinical failure.

Symptoms

Persistent fever, infection symptoms, and inflammation markers 48–72 hours after antibiotic start.

Management

Take ciprofloxacin 2 hours before or 6 hours after calcium carbonate. Apply the same interval for iron, zinc, magnesium, and aluminium-containing antacids. If timing separation is impossible (e.g. continuous calcium need), choose an alternative antibiotic (amoxicillin-clavulanate, a cephalosporin).

Pair details →Ciprofloxacin →

ModerateLevothyroxine sodiumThyroid hormones

Mechanism

Calcium binds levothyroxine in the gut as insoluble complexes, reducing absorption by 20–25%.

Symptoms

Return of hypothyroidism: fatigue, weight gain, cold intolerance, dry skin, low mood. In thyroid cancer, loss of TSH control.

Management

Take levothyroxine in the morning on empty stomach, 30–60 minutes before food and other drugs. Take calcium carbonate 4 hours after levothyroxine (e.g. at lunch or in the evening). Check TSH 6–8 weeks after starting calcium.

Pair details →Levothyroxine sodium →

MinorAcetylsalicylic acidAntiplatelet agents (low dose) / NSAIDs (analgesic dose)

Mechanism

Antacids accelerate renal aspirin elimination via urinary alkalinisation. At cardioprotective doses (75–100 mg/day), the effect is clinically minimal.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

At cardioprotective aspirin doses, no adjustment needed. At high anti-inflammatory doses (over 3 g/day) with simultaneous antacid for several days, efficacy may slightly drop — separate dosing by 2 hours.

Pair details →Acetylsalicylic acid →

MinorAmlodipineCalcium channel blockers (dihydropyridines)

Mechanism

No clinically significant direct interaction. Oral calcium does not affect amlodipine: vascular smooth muscle calcium channel blockade is intracellular and is not overcome by exogenous calcium.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No dose adjustment needed. In patients with hypertension and osteoporosis, the combination is standard.

Pair details →Amlodipine →

MinorCholecalciferolVitamins. Regulator of calcium-phosphorus metabolism

Mechanism

Vitamin D increases intestinal calcium absorption by activating calbindin in enterocytes. The synergistic effect benefits osteoporosis and calcium deficiency.

Symptoms

On a balanced dose, no symptoms. At excessive doses of vitamin D (over 4000 IU/day chronically) and calcium (over 1500 mg/day), hypercalcaemia risk: thirst, polyuria, nausea, weakness, arrhythmia.

Management

Standard combination in osteoporosis prevention and treatment: colecalciferol 800–2000 IU/day plus calcium 1000–1200 mg/day (counting dietary calcium). Check calcium and creatinine every 6 months in patients with chronic kidney disease or prior nephrolithiasis.

Pair details →Cholecalciferol →

MinorDoxycyclineTetracyclines

Mechanism

Doxycycline forms non-absorbable chelates with calcium in the gut (and with other polyvalent cations — magnesium, iron, aluminium). Doxycycline bioavailability falls by 50–80%.

Symptoms

Persistent infection symptoms 48–72 hours after antibiotic start, risk of clinical failure.

Management

Take doxycycline 2 hours before or 6 hours after calcium carbonate. Apply the same interval for iron, magnesium, zinc, and aluminium-containing antacids. If timing separation is impossible, choose an alternative antibiotic (amoxicillin, a cephalosporin).

Pair details →Doxycycline →

MinorLithiumPsycholeptics. Lithium

Mechanism

Calcium carbonate as an antacid mildly reduces lithium intestinal absorption, but no clinically significant drop in blood concentration has been documented.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No dose adjustment needed. Check lithium levels on the usual schedule (every 3 months on stable dose). With significant clinical changes (return of manic or depressive symptoms), check off-schedule.

Pair details →Lithium →

MinorMetforminBiguanides. Oral antihyperglycemic agents

Mechanism

Calcium carbonate slightly reduces metformin intestinal absorption when taken together. Clinically significant hyperglycaemia has not been described.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

Take metformin with or just after meals; take calcium carbonate 2 hours after meals or in the evening. On the combination, monitor on the usual schedule. In diabetics with osteoporosis, the combination is standard.

Pair details →Metformin →

MinorMetronidazoleImidazole derivatives (antiprotozoal / antibacterial)

Mechanism

Calcium carbonate as an antacid may theoretically reduce metronidazole absorption, but no clinically significant effect on antibacterial efficacy has been described.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

For short metronidazole courses (5–10 days), no specific adjustment needed. In Helicobacter pylori eradication (with bismuth or a PPI), the combination is standard.

Pair details →Metronidazole →

MinorSertralineSelective serotonin reuptake inhibitors (SSRIs)

Mechanism

Calcium carbonate and sertraline are metabolised by different pathways. No direct interaction.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No dose adjustment needed. In women with depression and osteoporosis, the combination is standard.

Pair details →Sertraline →

MinorSimeticoneDrugs for functional bowel disorders. Antifoaming agents

Mechanism

Simethicone is a surface-active silicone agent that is not absorbed in the gastrointestinal tract. No direct pharmacokinetic interaction with calcium carbonate.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No dose adjustment needed. The combination is standard in symptomatic formulations for bloating and heartburn.

Pair details →Simeticone →

Label mentions6 mentions

Verbatim lines from the interaction sections, in the language of the label

From this drug’s label

  • Moderatecorticosteroidesclass named in the label
    «Los corticosteroides sistémicos reducen la absorción de calcio. Durante su uso concomitante, puede ser necesario aumentar la dosis de Carbocal 600 mg comprimidos.»

    AEMPS, section 4.5 · Open on CIMA

  • Moderatedigitálicosclass named in the label
    «La hipercalcemia puede aumentar la toxicidad de los glucósidos cardiacos durante el tratamiento con calcio. Los pacientes deben controlarse mediante electrocardiograma (ECG) y niveles séricos de…»

    AEMPS, section 4.5 · Open on CIMA

  • Moderatetiazidasclass named in the label
    «Los diuréticos tiazídicos reducen la excreción urinaria de calcio. Debido al aumento del riesgo de hipercalcemia, debe controlarse regularmente el calcio sérico durante el uso concomitante de…»

    AEMPS, section 4.5 · Open on CIMA

  • bifosfonatosclass named in the label
    «Si se utiliza un bifosfonato o fluoruro de sodio de forma concomitante, esta preparación deberá administrarse al menos tres horas antes de la ingesta de Carbocal 600 mg comprimidos pues puede…»

    AEMPS, section 4.5 · Open on CIMA

  • quinolonasclass named in the label
    «La absorción de quinolonas podría verse perjudicada si se administra concomitantemente con calcio. Las quinolonas se deben tomar 2 horas antes o 6 horas depués de la ingesta de calcio.»

    AEMPS, section 4.5 · Open on CIMA

  • tetraciclinasclass named in the label
    «El carbonato cálcico puede interferir con la absorción de preparaciones de tetraciclinas administradas de forma concomitante. Por este motivo, las preparaciones de tetraciclinas deben administrarse…»

    AEMPS, section 4.5 · Open on CIMA

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Calcium carbonate used for?

Calcium carbonate is evaluated for the following indications with varying evidence strength: Mild hypocalcemia (evidence tier A), Antacid therapy for mild dyspepsia (evidence tier B), Calcium monotherapy for osteoporosis (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Calcium carbonate?

Common side effects of Calcium carbonate (≥ 1 in 100): Constipation, Flatulence, belching, Nausea. See the Safety section for uncommon and serious reactions.

Is Calcium carbonate safe during pregnancy?

AEMPS summary of product characteristics (section 4.6): calcium carbonate can be used during pregnancy. Daily calcium intake should not exceed 2,500 mg, because persistent hypercalcaemia has been linked to adverse effects on fetal development.

Is Calcium carbonate compatible with breastfeeding?

Calcium is an essential component of a lactating mother's diet. Calcium supplementation at physiological doses is safe and compatible with breastfeeding.

Who should not take Calcium carbonate?

Calcium carbonate is contraindicated in: Hypercalcemia of any cause; Hypercalciuria with stone disease risk; Active urolithiasis; Severe renal impairment (eGFR < 30 mL/min/1.73 m²); Sarcoidosis and other granulomatous diseases with hypercalcemia. Full list in the Safety section.

more calcium means stronger bones

beyond 1500 mg daily, additional calcium offers no extra benefit and increases hypercalciuria and stone disease risk.

every woman over 40 needs calcium for osteoporosis prevention

the 2018 USPSTF found no benefit of prophylactic supplementation in asymptomatic women. Adequate dietary intake is usually enough; supplements are indication-based after risk assessment.

calcium and vitamin D alone treat osteoporosis

confirmed osteoporosis requires disease-modifying therapy (bisphosphonates, denosumab, romosozumab). Calcium and vitamin D are background components.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Calcium + Cholecalciferol, Calcium D-glucarate, Chromium picolinate, Copper, Magnesium L-threonate (Magtein), Molybdenum, Selenium (oral salts and chelates: selenomethionine, sodium selenite, selenium yeast), Magnesium (oral salts: citrate, glycinate, oxide, sulfate)